Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
The Gorman-Rupp Company is a specialty industrial machinery business based in the US. The Gorman-Rupp Company shares (GRC) are listed on the NYSE and all prices are listed in US Dollars. The Gorman-Rupp Company employs 1,150 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$38.98|
|52-week range||$29.93 - $37.95|
|50-day moving average||$36.21|
|200-day moving average||$35.14|
|Wall St. target price||$40.00|
|Dividend yield||$0.61 (1.62%)|
|Earnings per share (TTM)||$1.10|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-08)||3.75%|
|1 month (2021-09-16)||6.07%|
|3 months (2021-07-16)||11.66%|
|6 months (2021-04-15)||15.09%|
|1 year (2020-10-15)||18.62%|
|2 years (2019-10-15)||13.38%|
|3 years (2018-10-15)||20.91%|
|5 years (2016-10-14)||58.71%|
Valuing The Gorman-Rupp Company stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of The Gorman-Rupp Company's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
The Gorman-Rupp Company's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 34x. In other words, The Gorman-Rupp Company shares trade at around 34x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
The Gorman-Rupp Company's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.06. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into The Gorman-Rupp Company's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
The Gorman-Rupp Company's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $47.2 million.
The EBITDA is a measure of a The Gorman-Rupp Company's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$353.5 million|
|Operating margin TTM||9.86%|
|Gross profit TTM||$89.6 million|
|Return on assets TTM||5.42%|
|Return on equity TTM||8.96%|
|Market capitalisation||$981.6 million|
TTM: trailing 12 months
There are currently 424,188 The Gorman-Rupp Company shares held short by investors – that's known as The Gorman-Rupp Company's "short interest". This figure is 9.1% up from 388,808 last month.
There are a few different ways that this level of interest in shorting The Gorman-Rupp Company shares can be evaluated.
The Gorman-Rupp Company's "short interest ratio" (SIR) is the quantity of The Gorman-Rupp Company shares currently shorted divided by the average quantity of The Gorman-Rupp Company shares traded daily (recently around 44324.764890282). The Gorman-Rupp Company's SIR currently stands at 9.57. In other words for every 100,000 The Gorman-Rupp Company shares traded daily on the market, roughly 9570 shares are currently held short.
However The Gorman-Rupp Company's short interest can also be evaluated against the total number of The Gorman-Rupp Company shares, or, against the total number of tradable The Gorman-Rupp Company shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case The Gorman-Rupp Company's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 The Gorman-Rupp Company shares in existence, roughly 20 shares are currently held short) or 0.018% of the tradable shares (for every 100,000 tradable The Gorman-Rupp Company shares, roughly 18 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against The Gorman-Rupp Company.
Find out more about how you can short The Gorman-Rupp Company stock.
Dividend payout ratio: 54.87% of net profits
Recently The Gorman-Rupp Company has paid out, on average, around 54.87% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.65% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), The Gorman-Rupp Company shareholders could enjoy a 1.65% return on their shares, in the form of dividend payments. In The Gorman-Rupp Company's case, that would currently equate to about $0.61 per share.
The Gorman-Rupp Company's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The Gorman-Rupp Company's most recent dividend payout was on 9 September 2021. The latest dividend was paid out to all shareholders who bought their shares by 11 August 2021 (the "ex-dividend date").
The Gorman-Rupp Company's shares were split on a 5:4 basis on 10 December 2013. So if you had owned 4 shares the day before before the split, the next day you'd have owned 5 shares. This wouldn't directly have changed the overall worth of your The Gorman-Rupp Company shares – just the quantity. However, indirectly, the new 20% lower share price could have impacted the market appetite for The Gorman-Rupp Company shares which in turn could have impacted The Gorman-Rupp Company's share price.
Over the last 12 months, The Gorman-Rupp Company's shares have ranged in value from as little as $29.9262 up to $37.95. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while The Gorman-Rupp Company's is 0.5069. This would suggest that The Gorman-Rupp Company's shares are less volatile than average (for this exchange).
The Gorman-Rupp Company designs, manufactures, and sells pumps and pump systems worldwide. The company's products include self-priming centrifugal, standard centrifugal, magnetic drive centrifugal, axial and mixed flow, vertical turbine line shaft, submersible, high pressure booster, rotary gear, diaphragm, bellows, and oscillating pumps. Its products are used in water, wastewater, construction, dewatering, industrial, petroleum, original equipment, agriculture, fire protection, military, and other liquid-handling applications, as well as in heating, ventilating, and air conditioning applications. The company markets its products through a network of distributors, manufacturers' representatives, third-party distributor catalogs, direct sales, and commerce. The Gorman-Rupp Company was founded in 1933 and is headquartered in Mansfield, Ohio. .
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
We’ve pulled a list together of the meme stocks being mentioned most on Reddit in the past 24 hours.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.